Freelite®

Freelite quantitatively measures serum kappa and lambda free light chains (FLCs) and can be used in initial testing, monitoring and prognosis of patients with suspected monoclonal gammopathies.

Performing Freelite and serum electrophoresis analysis provides an efficient initial diagnostic screen, and means that urine electrophoresis can be ordered more selectively.

• A simple and sensitive latex-enhanced immunoassay
• Based on polyclonal antisera to ensure recognition of the widest variety of free light chains
• Provides quantitative results quickly - results typically within 30 minutes
• Recommended by International and National guidelines
• Available on a wide range of nephelometric and turbidimetric analysers including Optilite and SPA_PLUS analysers from the Binding Site specifically designed for specialist protein testing

• Improved turn-around times for patient results compared to electrophoretic test methods
• Greater sensitivity than electrophoretic methods for the detection of FLCs
• Reliable results, with excellent precision, batch-to-batch consistency and linearity